INDICATIONS AND USAGE:
Cetrorelix Acetate for Injection 0.25 mg (Cetrorelix) is indicated for the inhibition of premature LH surges in women undergoing controlled ovarian stimulation. Cetrorelix should be prescribed by physicians who are experienced in fertility treatment.
IMPORTANT RISK INFORMATION:
Cetrorelix is contraindicated in women who exhibit hypersensitivity to Cetrorelix, mannitol or medicines similar to Cetrorelix, who exhibit prior hypersensitivity to GnRH or any other GnRH analogs, or who are pregnant, are breast-feeding or have severe kidney disease.
Warnings and Precautions
Ovarian Hyperstimulation Syndrome (OHSS), with or without blood vessel or lung problems, can occur with the use of fertility drugs.
Mild and short lasting injection reactions like reddening, itching and swelling at the injection sites may occur. Nausea and headache have also been reported.
Please click here for Full Prescribing Information.